NCT01200589 · Interventional trial
Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy
Overall registry status Terminated
Phase 3
Conditions Non-Hodgkin's Lymphoma
Delaware Valley sites
- Novartis Investigative Site · Willow Grove, PA · Montgomery County
First posted
Registry updated
Added to the directory